Science Daily November 10, 2012
A collaborative research effort between investigators at UTMB and Hospital for Special Surgery suggests that statins, traditionally used for cholesterol lowering, could be used in the management of individuals who are at risk for developing clotting because they have autoimmune antiphospholipid antibodies (aPL). The researchers then set out to test whether a statin called fluvastatin could reduce the proteins that were elevated in the individuals with aPLs. “Statins do more than just lowering cholesterol. They also have anti-inflammatory effects,” said UTMB’s Silvia Pierangeli. The news also appears in Science Codex, Bio-Medicine and Medical Xpress.